Profile
Sector:
HealthcareCountry:
United StatesIPO:
15 February 2022Website:
http://www.sunshinebiopharma.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 26 Jun 2024 23:57:05 GMTDividend
Analysts recommendations
Institutional Ownership
SBFM Latest News
Sunshine Biopharma (NASDAQ: SBFM ) stock is falling on Monday after the pharmaceutical company received a delisting notice from the Nasdaq Exchange. That delisting notice notes that shares of SBFM stock have been trading for less than the $1 minimum bid price for too long.
Sunshine Biopharma (NASDAQ: SBFM ) stock is falling on Friday after the pharmaceutical company revealed details of a private offering for its shares. Sunshine Biopharma has agreed to sell 5,952,381 units and pre-funded units at a purchase price of 84 cents per unit to a single healthcare-focused institutional investor.
Canadian biotech company Sunshine Biopharma (NASDAQ: SBFM ) is among the leaders in today's rather volatile session. Currently, shares of SBFM stock are up more than 60% after the company announced what appears to be incredible earnings.
What type of business is Sunshine Biopharma?
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.
What sector is Sunshine Biopharma in?
Sunshine Biopharma is in the Healthcare sector
What industry is Sunshine Biopharma in?
Sunshine Biopharma is in the Drug Manufacturers - Specialty & Generic industry
What country is Sunshine Biopharma from?
Sunshine Biopharma is headquartered in United States
When did Sunshine Biopharma go public?
Sunshine Biopharma initial public offering (IPO) was on 15 February 2022
What is Sunshine Biopharma website?
https://www.sunshinebiopharma.com
Is Sunshine Biopharma in the S&P 500?
No, Sunshine Biopharma is not included in the S&P 500 index
Is Sunshine Biopharma in the NASDAQ 100?
No, Sunshine Biopharma is not included in the NASDAQ 100 index
Is Sunshine Biopharma in the Dow Jones?
No, Sunshine Biopharma is not included in the Dow Jones index
When does Sunshine Biopharma report earnings?
The next expected earnings date for Sunshine Biopharma is 09 August 2024